Generic medications are just as safe and effective as their brand-name counterparts, and often cost less. To help educate patients about FDA’s rigorous review process, the economics of pricing, and related issues, FDA offers a range of educational materials, including videos, graphics, fact sheets,.
Similar Posts
Study Data Technical Conformance Guide – Technical Specifications Document
This technical specifications document represents the Food and Drug Administration’s (FDA’s) current thinking on this topic.SKNV. Pompano Beach, FL. Untitled Letter issued 09/16/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 09/16/2025
Short Title (70 char) SKNV. Pompano Beach, FL. Untitled Letter issued 09/16/2025
FEI Number 3012384835
Firm Name SKNV
Record Type Untitled Letter
State FL
Establishment Type Outsourcing FacilityFDA-TRACK: Biosimilar User Fee Act Procedural Notification Goals Summary
FDA-TRACK: Biosimilar User Fee Act Procedural Notification Goals Summarywww.mysteroidsmarket.com – 711353 – 07/17/2025
Unapproved New Drugs/MisbrandedMediNatura New Mexico, Inc. Issues Voluntary Nationwide Recall of ReBoost Nasal Spray Due to Microbial Contamination
FOR IMMEDIATE RELEASE – December 10, 2025 – Albuquerque, New Mexico, MediNatura New Mexico, Inc. is voluntarily recalling one lot of ReBoost Nasal Spray to the consumer level. The product has been found to contain yeast/mold and microbial contamination with one species identified as Achromobacter, aShilpa Medicare Limited – 11/21/2025
Shilpa Medicare Limited – 11/21/2025. Country: India. Record Type: 483